BELITE BIO INC (BLTE)
Institutional ownership reported to the SEC as of Q2 2026, across 18 quarters.
Calls and puts are the parts of reported value carried in derivative lines rather than shares, and they point in opposite directions: a manager holding calls is positioned for the security, one holding puts against it - or hedging shares they already own, which is why index funds carry so many. Most sites add the two together and report one figure, which averages away the only interesting part.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| Darwin Global Management, Ltd. | $456.6M | 3,077,219 | 12.14% | 3q | +0.6%+$2.9M |
| Paradigm Biocapital Advisors LP | $189.8M | 1,232,877 | 3.55% | 2q | +10.6%+$18.2M |
| RTW INVESTMENTS, LP | $110.2M | 715,332 | 0.94% | 4q | HELD |
| MILLENNIUM MANAGEMENT LLC | $76.2M | 494,564 | 0.03% | 4q | -13.2%-$11.6M |
| MAVERICK CAPITAL LTD | $61.0M | 396,311 | 0.54% | new | NEW |
| EVENTIDE ASSET MANAGEMENT, LLC | $60.2M | 390,829 | 0.80% | 4q | +9.3%+$5.1M |
| DEERFIELD MANAGEMENT COMPANY, L.P. | $55.0M | 357,199 | 0.57% | 3q | +17.5%+$8.2M |
| Holocene Advisors, LP | $38.7M | 251,035 | 0.09% | 3q | -49.2%-$37.5M |
| Logos Global Management LP | $38.5M | 250,000 | 1.66% | new | NEW |
| MORGAN STANLEY | $36.2M | 235,071 | 0.00% | 16q | +16.7%+$5.2M |
| UBS Group AG | $34.6M | 224,989 | 0.00% | 8q | -70.7%-$83.7M |
| CITADEL ADVISORS LLC | $28.7M | 186,168 | 0.00% | 8q | +9171.3%+$28.4M |
| GOLDMAN SACHS GROUP INC | $25.6M | 166,188 | 0.00% | 4q | +57.5%+$9.3M |
| Affinity Asset Advisors, LLC | $25.4M | 165,000 | 1.15% | 3q | +153.8%+$15.4M |
| MPM BIOIMPACT LLC | $21.1M | 137,208 | 1.29% | 3q | +55.8%+$7.6M |
| BANK OF AMERICA CORP /DE/ | $19.2M | 124,783 | 0.00% | 12q | +3202.9%+$18.6M |
| Patient Square Capital LP | $16.9M | 110,000 | 2.62% | 2q | -5.7%-$1.0M |
| Duquesne Family Office LLC | $16.3M | 106,100 | 0.31% | 2q | HELD |
| PRICE T ROWE ASSOCIATES INC /MD/ | $16.3M | 105,859 | 0.00% | 2q | -62.4%-$27.1M |
| JANE STREET GROUP, LLC | $10.1M | 65,801 | 0.00% | 3q | +438.4%+$8.3M |
| BNP PARIBAS FINANCIAL MARKETS | $8.8M | 57,125 | 0.00% | 5q | +75.6%+$3.8M |
| RENAISSANCE TECHNOLOGIES LLC | $8.6M | 55,763 | 0.01% | 2q | +7.2%+$579.4K |
| Point72 Asset Management, L.P. | $7.9M | 51,186 | 0.01% | new | NEW |
| Soleus Capital Management, L.P. | $7.8M | 50,524 | 0.27% | new | NEW |
| Trexquant Investment LP | $7.6M | 49,516 | 0.04% | 2q | +228.5%+$5.3M |
| TWO SIGMA INVESTMENTS, LP | $5.9M | 38,100 | 0.00% | new | NEW |
| PFM Health Sciences, LP | $5.4M | 34,803 | 0.46% | 3q | -41.4%-$3.8M |
| JPMORGAN CHASE & CO | $5.1M | 33,181 | 0.00% | 11q | +1105933.3%+$5.1M |
| Walleye Capital LLC | $4.9M | 31,721 | 0.02% | new | NEW |
| Artia Global Partners LP | $3.8M | 24,989 | 0.71% | 3q | HELD |
| GEODE CAPITAL MANAGEMENT, LLC | $3.5M | 22,640 | 0.00% | 12q | +117.1%+$1.9M |
| BALANCE CAPITAL PARTNERS L.P. | $3.5M | 22,500 | 2.49% | 2q | +55.2%+$1.2M |
| NATIONAL BANK OF CANADA /FI/ | $3.1M | 20,000 | 0.00% | new | NEW |
| STATE STREET CORP | $2.5M | 15,924 | 0.00% | 16q | -0.8%-$19.1K |
| Verdad Advisers, LP | $2.1M | 13,758 | 2.03% | 2q | HELD |
| ORBIMED ADVISORS LLC | $2.0M | 13,300 | 0.04% | new | NEW |
| TD Asset Management Inc | $2.0M | 13,010 | 0.00% | 2q | -61.1%-$3.1M |
| BOOTHBAY FUND MANAGEMENT, LLC | $2.0M | 12,733 | 0.03% | new | NEW |
| Qube Research & Technologies Ltd | $1.9M | 12,171 | 0.00% | new | NEW |
| Lighthouse Investment Partners, LLC | $1.5M | 10,000 | 0.04% | new | NEW |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $1.5M | 9,820 | 0.00% | 2q | -49.9%-$1.5M |
| HighVista Strategies LLC | $1.5M | 9,554 | 0.34% | 2q | +18.9%+$234.2K |
| Squarepoint Ops LLC | $1.4M | 8,785 | 0.00% | 2q | -48.3%-$1.3M |
| BARCLAYS PLC | $1.1M | 6,822 | 0.00% | 3q | HELD |
| Capricorn Fund Managers Ltd | $985.5K | 6,400 | 0.08% | new | NEW |
| Voleon Capital Management LP | $968.4K | 6,289 | 0.02% | 2q | -20.2%-$245.5K |
| GSA CAPITAL PARTNERS LLP | $672.0K | 4,364 | 0.04% | 3q | +165.3%+$418.7K |
| SmartHarvest Portfolios, LLC | $671.2K | 4,359 | 0.22% | 3q | +4.1%+$26.5K |
| XTX Topco Ltd | $667.2K | 4,333 | 0.01% | 2q | -71.2%-$1.7M |
| Mariner, LLC | $590.5K | 3,835 | 0.00% | new | NEW |
| Entropy Technologies, LP | $569.7K | 3,700 | 0.02% | new | NEW |
| High Net Worth Advisory Group LLC | $538.9K | 3,500 | 0.11% | 4q | HELD |
| FMR LLC | $477.4K | 3,100 | 0.00% | new | NEW |
| AMERIPRISE FINANCIAL INC | $466.4K | 3,029 | 0.00% | 4q | +9.5%+$40.3K |
| Engineers Gate Manager LP | $427.0K | 2,773 | 0.01% | 2q | +11.4%+$43.7K |
| Virtus Investment Advisers, LLC | $364.8K | 2,369 | 0.08% | 6q | +22.8%+$67.8K |
| FRED ALGER MANAGEMENT, LLC | $326.3K | 2,119 | 0.00% | 3q | -96.6%-$9.3M |
| Jain Global LLC | $323.5K | 2,101 | 0.00% | new | NEW |
| Arrowpoint Investment Partners (Singapore) Pte. Ltd. | $309.2K | 2,008 | 0.07% | 3q | -66.6%-$615.3K |
| DYMON ASIA CAPITAL (SINGAPORE) PTE. LTD. | $292.6K | 1,900 | 0.01% | 2q | HELD |
| GAMMA Investing LLC | $259.6K | 1,686 | 0.01% | 11q | -1.2%-$3.2K |
| R Squared Ltd | $206.0K | 1,338 | 0.11% | new | NEW |
| Independent Advisor Alliance | $203.1K | 1,319 | 0.00% | 3q | HELD |
| SG Americas Securities, LLC | $141.0K | 913 | 0.00% | 3q | -57.4%-$190.1K |
| Mirae Asset Global Investments Co., Ltd. | $72.4K | 470 | 0.00% | 3q | -28.5%-$28.8K |
| ROYAL BANK OF CANADA | $50.0K | 322 | 0.00% | 3q | -85.7%-$300.5K |
| Bayforest Capital Ltd | $47.3K | 307 | 0.04% | new | NEW |
| WELLS FARGO & COMPANY/MN | $19.1K | 124 | 0.00% | 3q | HELD |
| E Fund Management (Hong Kong) Co., Ltd. | $17.4K | 113 | 0.01% | 2q | +36.1%+$4.6K |
| CITIGROUP INC | $7.2K | 47 | 0.00% | 4q | +4600.0%+$7.1K |
| JONES FINANCIAL COMPANIES LLLP | $4.8K | 32 | 0.00% | 3q | +433.3%+$3.9K |
| SBI Securities Co., Ltd. | $3.4K | 22 | 0.00% | 7q | HELD |
| Rossby Financial, LCC | $3.1K | 20 | 0.00% | 4q | -63.6%-$5.4K |
| WEST PACES ADVISORS INC. | $2.8K | 18 | 0.00% | new | NEW |
| NISA INVESTMENT ADVISORS, LLC | $2.6K | 17 | 0.00% | 2q | +30.8% |
| Bell Investment Advisors, Inc | $2.0K | 13 | 0.00% | 2q | +225.0%+$1.4K |
| EverSource Wealth Advisors, LLC | $924 | 6 | 0.00% | 5q | -99.6%-$246.7K |
| Farther Finance Advisors, LLC | $616 | 4 | 0.00% | 3q | -73.3%-$1.7K |
| FIDUCIARY FINANCIAL ADVISORS | $462 | 3 | 0.00% | new | NEW |
| Arax Advisory Partners | $308 | 2 | 0.00% | new | NEW |
What the insiders did
Open market purchases and sales reported on Form 4 in the last 180 days. Grants, option exercises and shares surrendered to cover tax are left out: they are compensation rather than a decision to buy or sell. Where a broker filled one order in tranches the lines are summed, because it was one decision.
Officers and directors
| Date | Insider | Role | Side | Shares | Value |
|---|---|---|---|---|---|
| 2026-09-04 | Lin Yu-Hsin | Chief Executive Officer | Sold | 74,435 | $14.0M ×14 |
| 2026-09-04 | Chuang Hao-Yuan | Chief Financial Officer | Sold | 49,433 | $9.3M ×14 |
| 2026-09-08 | Lin Yu-Hsin | Chief Executive Officer | Sold | 26,000 | $5.1M ×5 |
| 2026-09-08 | Chuang Hao-Yuan | Chief Financial Officer | Sold | 17,962 | $3.5M ×5 |
| 2026-06-18 | Scholl Hendrik Peter | Chief Medical Officer | Sold | 10,000 | $1.5M ×5 |
| 2026-06-16 | Scholl Hendrik Peter | Chief Medical Officer | Sold | 10,000 | $1.4M ×8 |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q3 2026 | 11 | $1.6M | 9,542 | 2 | 5 | 2 | 0.0% |
| Q2 2026 | 80 | $1.4B | 9,473,413 | 21 | 28 | 21 | 0.0% |
| Q1 2026 | 75 | $1.4B | 9,116,527 | 28 | 24 | 14 | 0.0% |
| Q4 2025 | 69 | $1.2B | 7,191,093 | 36 | 17 | 10 | 0.0% |
| Q3 2025 | 34 | $170.1M | 2,298,278 | 16 | 12 | 5 | 0.0% |
| Q2 2025 | 18 | $4.5M | 78,139 | 6 | 6 | 5 | 0.0% |
| Q1 2025 | 18 | $9.9M | 149,657 | 7 | 4 | 5 | 0.0% |
| Q4 2024 | 21 | $17.8M | 282,406 | 7 | 6 | 4 | 0.0% |
| Q3 2024 | 15 | $4.0M | 85,055 | 6 | 5 | 2 | 0.0% |
| Q2 2024 | 11 | $8.5M | 186,656 | 2 | 2 | 6 | 0.0% |
| Q1 2024 | 11 | $2.7M | 70,950 | 0 | 2 | 8 | 0.0% |
| Q4 2023 | 17 | $8.8M | 191,797 | 10 | 3 | 1 | 0.0% |
| Q3 2023 | 7 | $3.2M | 99,593 | 3 | 2 | 1 | 0.0% |
| Q2 2023 | 6 | $14.9M | 1,040,502 | 1 | 2 | 2 | 0.0% |
| Q1 2023 | 8 | $25.4M | 850,185 | 1 | 2 | 4 | 0.0% |
| Q4 2022 | 7 | $25.9M | 857,329 | 3 | 2 | 2 | 0.0% |
| Q3 2022 | 7 | $2.1M | 60,883 | 5 | 1 | 0 | 0.0% |
| Q2 2022 | 6 | $2.1M | 68,935 | 6 | 0 | 0 | 0.0% |
